Literature DB >> 20622882

Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.

Maziar Divangahi1, Danielle Desjardins, Cláudio Nunes-Alves, Heinz G Remold, Samuel M Behar.   

Abstract

The fate of infected macrophages has an essential role in protection against Mycobacterium tuberculosis by regulating innate and adaptive immunity. M. tuberculosis exploits cell necrosis to exit from macrophages and spread. In contrast, apoptosis, which is characterized by an intact plasma membrane, is an innate mechanism that results in lower bacterial viability. Virulent M. tuberculosis inhibits apoptosis and promotes necrotic cell death by inhibiting production of prostaglandin E(2). Here we show that by activating the 5-lipoxygenase pathway, M. tuberculosis not only inhibited apoptosis but also prevented cross-presentation of its antigens by dendritic cells, which impeded the initiation of T cell immunity. Our results explain why T cell priming in response to M. tuberculosis is delayed and emphasize the importance of early immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622882      PMCID: PMC3150169          DOI: 10.1038/ni.1904

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  50 in total

1.  Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major.

Authors:  R Lira; M Doherty; G Modi; D Sacks
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

Authors:  J Keane; H G Remold; H Kornfeld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

Review 3.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

4.  Cytosolic phospholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra.

Authors:  L Duan; H Gan; J Arm; H G Remold
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

5.  Organ-specific CD4+ T cell response during Listeria monocytogenes infection.

Authors:  Mischo Kursar; Kerstin Bonhagen; Anne Köhler; Thomas Kamradt; Stefan H E Kaufmann; Hans-Willi Mittrücker
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

6.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

7.  Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis.

Authors:  Lei Duan; Huixian Gan; David E Golan; Heinz G Remold
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

8.  Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation.

Authors:  L Ramachandra; E Noss; W H Boom; C V Harding
Journal:  J Exp Med       Date:  2001-11-19       Impact factor: 14.307

9.  Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells.

Authors:  U Yrlid; M J Wick
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

Review 10.  Mycobacterium and the coat of many lipids.

Authors:  David G Russell; Henry C Mwandumba; Elizabeth E Rhoades
Journal:  J Cell Biol       Date:  2002-07-29       Impact factor: 10.539

View more
  114 in total

1.  Hypercholesterolemic LDL receptor-deficient mice mount a neutrophilic response to tuberculosis despite the timely expression of protective immunity.

Authors:  Gregory W Martens; Therese Vallerskog; Hardy Kornfeld
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

2.  Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.

Authors:  David M Tobin; Francisco J Roca; Sungwhan F Oh; Ross McFarland; Thad W Vickery; John P Ray; Dennis C Ko; Yuxia Zou; Nguyen D Bang; Tran T H Chau; Jay C Vary; Thomas R Hawn; Sarah J Dunstan; Jeremy J Farrar; Guy E Thwaites; Mary-Claire King; Charles N Serhan; Lalita Ramakrishnan
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

3.  HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis.

Authors:  Jonathan Braverman; Kimberly M Sogi; Daniel Benjamin; Daniel K Nomura; Sarah A Stanley
Journal:  J Immunol       Date:  2016-07-18       Impact factor: 5.422

Review 4.  Apoptosis inhibition by intracellular bacteria and its consequence on host immunity.

Authors:  Samuel M Behar; Volker Briken
Journal:  Curr Opin Immunol       Date:  2019-06-19       Impact factor: 7.486

Review 5.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

Review 6.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 7.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

8.  Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages From Diabetic Mice.

Authors:  Nuria Martinez; Natkunam Ketheesan; Kim West; Therese Vallerskog; Hardy Kornfeld
Journal:  J Infect Dis       Date:  2016-09-13       Impact factor: 5.226

9.  Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells.

Authors:  M Jeyanathan; S McCormick; R Lai; S Afkhami; C R Shaler; C N Horvath; D Damjanovic; A Zganiacz; N Barra; A Ashkar; M Jordana; N Aoki; Z Xing
Journal:  Mucosal Immunol       Date:  2013-10-30       Impact factor: 7.313

10.  Tuberculosis immunopathology: the neglected role of extracellular matrix destruction.

Authors:  Paul T Elkington; Jeanine M D'Armiento; Jon S Friedland
Journal:  Sci Transl Med       Date:  2011-02-23       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.